Christopher Posner
2021
Compensation breakdown
| Bonus | $268,000 |
|---|---|
| Option Awards | $6,885,579 |
| Salary | $116,167 |
| Stock Awards | $2,583,896 |
| Other | $47,734 |
| Total | $9,901,376 |
Posner received $6.9M in option awards, accounting for 70% of the total pay in 2021.
Posner also received $268K in bonus, $116.2K in salary, $2.6M in stock awards and $47.7K in other compensation.
Rankings
In 2021, Christopher Posner's compensation ranked 1,054th out of 12,415 executives tracked by ExecPay. In other words, Posner earned more than 91.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,054 out of 12,415 | 92nd |
Division Manufacturing | 358 out of 5,505 | 94th |
Major group Chemicals And Allied Products | 125 out of 2,375 | 95th |
Industry group Drugs | 106 out of 2,096 | 95th |
Industry Pharmaceutical Preparations | 72 out of 1,546 | 95th |
Pay ratio
| Christopher Posner's Pay | $9,901,376 |
|---|---|
| Median Employee's Pay | $192,240 |
| Pay Ratio | 52to 1 |
In 2021, the annual total compensation of Christopher Posner was $9,901,376.
The annual total compensation of the median employee at Cara Therapeutics was $192,240.
The ratio of Christopher Posner's pay to the pay of median employee was therefore 52 to one.
Posner's colleagues
We found five more compensation records of executives who worked with Christopher Posner at Cara Therapeutics in 2021.
2021
Derek Chalmers
Cara Therapeutics
Chief Executive Officer
2021
Frédérique Menzaghi
Cara Therapeutics
Chief Scientific Officer
2021
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
2021
Scott Terrillion
Cara Therapeutics
General Counsel
2021
Thomas Reilly
Cara Therapeutics